Balance Sheet
Accounts PayablesAssetsCash & EquivalentsConvertible DebtCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOther Non-Current AssetsPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Long Term DebtTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Abivax (ABVX) Non-Current Debt: 2022-2024

Historic Non-Current Debt for Abivax (ABVX) over the last 3 years, with Dec 2024 value amounting to $74.8 million.

  • Abivax's Non-Current Debt rose 72.80% to $73.8 million in Q4 2024 from the same period last year, while for Dec 2024 it was $73.8 million, marking a year-over-year increase of 72.80%. This contributed to the annual value of $74.8 million for FY2024, which is 74.09% up from last year.
  • According to the latest figures from FY2024, Abivax's Non-Current Debt is $74.8 million, which was up 74.09% from $42.9 million recorded in FY2023.
  • In the past 5 years, Abivax's Non-Current Debt ranged from a high of $74.8 million in FY2024 and a low of $17.1 million during FY2022.
  • Moreover, its 3-year median value for Non-Current Debt was $42.9 million (2023), whereas its average is $44.9 million.
  • Data for Abivax's Non-Current Debt shows a peak YoY spiked of 150.86% (in 2023) over the last 5 years.
  • Over the past 3 years, Abivax's Non-Current Debt (Yearly) stood at $17.1 million in 2022, then surged by 150.86% to $42.9 million in 2023, then soared by 74.09% to $74.8 million in 2024.